1 / 19

Nephropathology Slide Seminar: Case 2 European Congress of Pathology 30.8.2011

Nephropathology Slide Seminar: Case 2 European Congress of Pathology 30.8.2011. Anne Raisanen-Sokolowski, MD, PhD Transplantation Laboratory Helsinki University Central Hospital Helsinki, Finland. Patient data 1. 53 years old, previously healthy male

bart
Download Presentation

Nephropathology Slide Seminar: Case 2 European Congress of Pathology 30.8.2011

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Nephropathology Slide Seminar: Case 2European Congress of Pathology 30.8.2011 Anne Raisanen-Sokolowski, MD, PhD Transplantation Laboratory Helsinki University Central Hospital Helsinki, Finland

  2. Patient data 1 • 53 years old, previously healthy male • One year ago vision began to worsen, diagnosed and treated as iritis • Thereafter fever (ad 39°C) and malaise for 6 months. • He suffered malfunction of intestine, edema in the lower extremities and muscle weakness, loss of appetite, weight loss

  3. Patient data 2 • The patient presented with: • tingling in finger tips and polyneuropathy by ENMG • hepatosplenomegalia • Ultrasound: several focal defects in liver, suspicion of metastasis • Biopsy: necrosis -> suspicion of Tbc -> treatment started -> laboratory findings negative • Ascites • Hypogonadism (low testosterone)

  4. Patient data 3 • The patient presented with: • paraproteinemia in plasma (kappa light chain, 3-10 g/l) • crista biopsy 10% plasma cells • hematuria (>20 erytrocytes/hpf) • proteinuria (dU-Prot 0,32-0,42 g/day, P-Alb 27 g/l, Crea 103 mmol/l) • Cachexia • Kidney biopsy taken

  5. Immunofluoresence study • Performed in frozen sections • IgG, IgA, IgM, C3, C1q, fibrinogen, kappa and lambda were negative

  6. Biopsy findings • Glomeruli • lobular and mesangial proliferation • GBM duplication, mesangial interposition • no immune deposit (IF and EM negative) • Tubuli and vessels • unremarkable

  7. Diagnosis • Membranoproliferative glomerulonephritis associated with POEMS syndrome • Polyneuropathy • Organomegaly (hepatosplenomegaly) • Endocrinopathy (hypogonadism) • M-component (kappa light chain) in plasma • Skin lesions (none) Nakamoto et al: A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome. NDT 1999: 14:2370-2378

  8. POEMS syndrome 1 • POEMS syndrome is a rare paraneoplastic syndrome secondary to plasma cell dyscrasia • Usually lambda light chain (95%) • Incidence peaks in 5th and 6th decade of life, unlike multiple myeloma (7-8th) Dispenzieri: POEMS syndrome. Blood Reviews 2007: 21, 285-299

  9. POEMS syndrome 2 • Complex pathogenesis: elevation of proangiogenic and proinflammatory cytokines are hallmarks of this disorder • Patients with POEMS have elevated VEGF levels in plasma, serum, ascites and cerebrospinal fluid Dispenzieri: POEMS syndrome. Blood Reviews 2007: 21, 285-299

  10. POEMS syndrome 3 • VEGF is the dominant driving cytokine • Targets endothelial cells and induces an increase in vascular permeability • Important in angiogenesis and osteogenesis • VEGF is expressed by osteoblasts, in bone tissue, macrophages, tumor cells (including plasma cells), megakaryocytes and platelets • IL-1b and IL-6 stimulate VEGF production Dispenzieri: POEMS syndrome. Blood Reviews 2007: 21, 285-299

  11. Pathological features of POEMS nephropathy • Glomerular enlargement • Cell proliferation and swelling • Mesangial loosening and mesangiolysis • Microaneurysms • Nodular-like lesions • Infiltration of plasma cells and mononuclear cells • Tubular atrophy and interstitial fibrosis • Acute tubular necrosis • No immune deposits Nakamoto et al: A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome. NDT 1999: 14:2370-2378

  12. Treatment • No randomized, controlled trials in POEMS • Radiation therapy, chemotherapy, corticosteroids, anti-VEGF mAb (Bevacizumab, Avestin) and stem cell transplantation • Case Patient received cyclic chemotherapy-corticosteroids-Bevacizumab treatment for 11 months, remission -> autologous stem cell transplantation 3/2011 ->5/2011 in remission Dispenzieri: POEMS syndrome. Blood Reviews 2007: 21, 285-299

  13. If we knew what we were doing it would not be called research A. Einstein Midnight Sun in Pyhatunturi, Lapland, July 14, 2011 at 23.28

More Related